Elanco Animal Health, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US28414H1032
USD
21.99
-0.19 (-0.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
1,241.00
1,193.00
1,020.00
1,030.00
1,184.00
1,205.00
1,035.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,241.00
1,193.00
1,020.00
1,030.00
1,184.00
1,205.00
1,035.00
Raw Material Cost
664.00
637.00
631.00
625.00
626.00
648.00
654.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
70.00
53.00
62.00
85.00
65.00
66.00
67.00
Selling and Distribution Expenses
400.00
341.00
300.00
323.00
354.00
337.00
292.00
Other Expenses
2.20
4.10
1.90
0.20
2.40
2.10
1.20
Total Expenditure (Excl Depreciation)
1,156.00
1,072.00
1,012.00
1,035.00
1,069.00
1,072.00
1,025.00
Operating Profit (PBDIT) excl Other Income
85
121
8
-5
115
133
10
Other Income
2.00
16.00
35.00
657.00
-5.00
0.00
-39.00
Operating Profit (PBDIT)
256.00
298.00
207.00
822.00
272.00
299.00
142.00
Interest
70.00
53.00
62.00
85.00
65.00
66.00
67.00
Exceptional Items
8.00
-24.00
-32.00
-8.00
-77.00
-55.00
-31.00
Gross Profit (PBDT)
577.00
556.00
389.00
405.00
558.00
557.00
381.00
Depreciation
169.00
161.00
164.00
170.00
162.00
166.00
171.00
Profit Before Tax
25.00
60.00
-51.00
559.00
-32.00
12.00
-127.00
Tax
14.00
-7.00
-43.00
195.00
18.00
-20.00
14.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
11.00
67.00
-8.00
364.00
-50.00
32.00
-141.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
11.00
67.00
-8.00
364.00
-50.00
32.00
-141.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
11.00
67.00
-8.00
364.00
-50.00
32.00
-141.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,775.00
6,353.00
6,096.00
6,523.00
5,942.00
6,056.00
6,223.00
Earnings per share (EPS)
0.02
0.14
-0.02
0.73
-0.1
0.06
-0.29
Diluted Earnings per share
0.02
0.14
-0.02
0.73
-0.1
0.06
-0.29
Operating Profit Margin (Excl OI)
6.85%
10.14%
0.78%
-0.49%
9.71%
11.04%
0.97%
Gross Profit Margin
15.63%
18.52%
11.08%
70.78%
10.98%
14.77%
4.25%
PAT Margin
0.89%
5.62%
-0.78%
35.34%
-4.22%
2.66%
-13.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 4.02% vs 16.96% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -83.58% vs 937.50% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -9.93% vs 63.95% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 32.08% vs -14.52% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Elanco Animal Health, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,241.00
316.96
924.04
291.53%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,241.00
316.96
924.04
291.53%
Raw Material Cost
664.00
105.82
558.18
527.48%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
70.00
4.74
65.26
1,376.79%
Selling and Distribution Expenses
400.00
110.26
289.74
262.78%
Other Expenses
2.20
2.13
0.07
3.29%
Total Expenditure (Excl Depreciation)
1,156.00
242.12
913.88
377.45%
Operating Profit (PBDIT) excl Other Income
85.00
74.85
10.15
13.56%
Other Income
2.00
5.74
-3.74
-65.16%
Operating Profit (PBDIT)
256.00
107.70
148.30
137.70%
Interest
70.00
4.74
65.26
1,376.79%
Exceptional Items
8.00
-98.71
106.71
108.10%
Gross Profit (PBDT)
577.00
211.14
365.86
173.28%
Depreciation
169.00
27.11
141.89
523.39%
Profit Before Tax
25.00
-22.86
47.86
209.36%
Tax
14.00
-5.18
19.18
370.27%
Provisions and contingencies
0
0
0.00
Profit After Tax
11.00
-17.70
28.70
162.15%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
11.00
-17.70
28.70
162.15%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11.00
-17.70
28.70
162.15%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
6,775.00
1,918.81
4,856.19
253.08%
Earnings per share (EPS)
0.02
-0.11
0.13
118.18%
Diluted Earnings per share
0.02
-0.11
0.13
118.18%
Operating Profit Margin (Excl OI)
6.85%
23.61%
0.00
-16.76%
Gross Profit Margin
15.63%
1.34%
0.00
14.29%
PAT Margin
0.89%
-5.58%
0.00
6.47%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 124.10 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.02% vs 16.96% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 4.81% vs 12.02% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.10 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -83.58% vs 937.50% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 122.00% vs 48.45% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.40 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -9.93% vs 63.95% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -8.30% vs 20.43% in Jun 2024

Quarterly - Interest
Interest 7.00 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 32.08% vs -14.52% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 7.69% vs -36.89% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.85%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024